PMDA — authorised 20 September 2019
- Marketing authorisation holder: Takeda Pharmaceutical Company Limited
- Status: approved
PMDA authorised Trintellix on 20 September 2019
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 20 September 2019.
Takeda Pharmaceutical Company Limited holds the Japanese marketing authorisation.